Delivery Order SPE2DB20D2104-SPE2DB23FR79M
Award Date 1/13/23
Potential Completion Date 1/17/23
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,471.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has a completion date of July 10, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,714.39 firm fixed-price delivery order is for the supply of LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of October 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of LIALDA DR 1.2 GM TABLET 120S. The contract has a firm fixed price of $3,236.85 and a period of performance through March 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,049.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 120 tablets of the prescription medication LIALDA DR 1.2 GM with a completion date of February 2, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 indefinite delivery contract with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,150 units of the prescription drug Lialda (mesalamine) in 120-count tablet bottles. The $2,807.73 firm fixed-price contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on July 24, 2025, for LIALDA DR 1.2 GM Tablet 120s, a pharmaceutical product used in the treatment of inflammatory bowel disease. This competitively awarded, firm fixed-price contract carries a ceiling value of $8,154.24 and is scheduled for completion by July 25, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,696.67 contract is for the supply of 120 tablets of the drug Lialda (mesalamine 1.2 gram) to support military and federal healthcare programs. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,514.61 for the supply of the pharmaceutical product LIALDA DR 1.2 GM TABLET 120S. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,238.51 firm fixed-price delivery order contract is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of May 28, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,396.75 firm fixed-price contract is for the delivery of 120 tablets of 1.2 gram Mesalamine, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of April 10, 2025 and is not associated with any set-aside requirements. AmerisourceBergen holds a significant...